AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 7128220
Drug: Theophylline (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (high dose: 16.0-23.6 micrograms/ml)
Trial: 30409023
Drug: 6% hypertonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6% hypertonic saline (HS) inhalation, twice daily for 52 weeks
Trial: 30409023
Drug: 0.9% isotonic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.9% isotonic saline (IS) inhalation, twice daily for 52 weeks
Trial: 28008093
Drug: Intravenous thrombolytics
RxNorm normalized name: thrombocytin
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous thrombolytics (alteplase)
Trial: 19824382
Drug: Prostamol-UNO 320
RxNorm normalized name: unoprostone
DrugBank: Unoprostone (DB06826)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prostamol-UNO 320 mg/day for 36 months
Trial: 17145264
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg orally 2-3 hours before MRCP
Trial: 3612496
Drug: Lignocaine HCl
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lignocaine HCl 120 mg
Trial: 3612496
Drug: MEGX HCl
RxNorm normalized name: Chlorpromazine Hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MEGX HCl 120 mg
Trial: 3612496
Drug: Lignocaine HCl
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lignocaine HCl 120 mg + MEGX HCl 120 mg
Trial: 25767371
Drug: Lobeglitazone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lobeglitazone (0.5 mg) with warfarin (25 mg) on day 5
Trial: 19386947
Drug: Warfarin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (25 mg) alone
Trial: 23067366
Drug: Celecoxib 200
RxNorm normalized name: celecoxib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 200 mg/day for 12 months
Trial: 16608035
Drug: Intraoperative adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraoperative adjuvant therapy (hepatectomy plus microwave coagulonecrotic therapy or radiofrequency ablation)
Trial: 16608035
Drug: Postoperative adjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative adjuvant therapy (transcatheter arterial embolization)
Trial: 9375593
Drug: Pimozide treatment
RxNorm normalized name: Pimozide
DrugBank: Pimozide (DB01100)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pimozide treatment for 6 weeks
Trial: 3890521
Drug: Oral glucose-electrolyte
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucose-electrolyte solution with 60 mEq/L sodium and 2% glucose
Trial: 3890521
Drug: Oral glucose-electrolyte
RxNorm normalized name: glucose Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral glucose-electrolyte solution with 30 mEq/L sodium and 5% glucose
Trial: 27121539
Drug: Daily buprenorphine-naloxone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily buprenorphine-naloxone (BP-NLX)
Trial: 23734933
Drug: Telaprevir-based triple
RxNorm normalized name: Telaprevir
DrugBank: Telaprevir (DB05521)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Telaprevir-based triple therapy (T12/PR24 group)
Trial: 20484150
Drug: Hydrocortisone (0.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocortisone (0.6 mg/kg i.v. bolus)
Trial: 3516407
Drug: Glycinated aspirin
RxNorm normalized name: aspirin / glycine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycinated aspirin swallowed without water (600 mg)
Trial: 3516407
Drug: Soluble aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soluble aspirin swallowed with water (600 mg)
Trial: 3516407
Drug: Both treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatments (Glycinated aspirin and Soluble aspirin)
Trial: 26613823
Drug: 30 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 μg ethinyl estradiol (EE) with 3mg drospirenone
Trial: 26613823
Drug: 20 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 μg ethinyl estradiol (EE) with 3mg drospirenone
Trial: 26573461
Drug: Cost-per-vaccinated child
RxNorm normalized name: Senna-Relief Childs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cost-per-vaccinated child excluding vaccine purchase
Trial: 15985589
Drug: Early withdrawal
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early withdrawal of antiepileptic drugs
Trial: 10543667
Drug: Nitrendipine 5
RxNorm normalized name: nitrendipine 5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine 5 mg twice daily
Trial: 10543667
Drug: Nitrendipine 10
RxNorm normalized name: nitrendipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine 10 mg twice daily
Trial: 8677941
Drug: Interferon therapy
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon therapy (natural alpha-interferon, 6 MU daily for 2 weeks, then 3 times a week for 22 weeks)
Trial: 8677941
Drug: Interferon therapy
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon therapy (natural alpha-interferon, 6 MU daily for 8 weeks, then 2 times a week for 12 weeks)
Trial: 29993146
Drug: Doxycycline 100
RxNorm normalized name: doxycycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 100 mg/d plus adapalene gel 0.1%
Trial: 21561497
Drug: Stepped smoking
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Stepped smoking cessation intervention based on the transtheoretical model of change, involving 6-month implementation of recommendations from a Clinical Practice Guideline including brief motivational interviews, brief intervention, intensive intervention with pharmacotherapy, and reinforcing intervention.
Trial: 16686908
Drug: Prophylaxis treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylaxis treatment for migraine
Trial: 2125252
Drug: Dietary therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary therapy alone
Trial: 8989010
Drug: 500 mL
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mL of hetastarch solution
Trial: 8989010
Drug: 1000 mL
RxNorm normalized name: TPN Bag 1000 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mL of lactated Ringer's solution
Trial: 7655330
Drug: 10 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g/day ground flaxseed
Trial: 2106401
Drug: Procainamide (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procainamide (750 mg)
Trial: 2106401
Drug: Tocainide (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocainide (600 mg)
Trial: 2106401
Drug: Encainide (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Encainide (50 mg)
Trial: 346257
Drug: Indomethacin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (100 mg per day) for 7 days
Trial: 21969227
Drug: Vorapaxar 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vorapaxar 40 mg single dose
Trial: 21969227
Drug: Vorapaxar 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vorapaxar 2.5 mg daily maintenance dose
Trial: 21969227
Drug: Vorapaxar (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vorapaxar (various doses: 5, 10, 20, or 40 mg single doses; 0.5, 1, or 2.5 mg once daily)
Trial: 21969227
Drug: Vorapaxar (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vorapaxar (various doses)
Trial: 19852833
Drug: Erythropoietin dose
RxNorm normalized name: Erythropoietin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythropoietin dose
Trial: 17443852
Drug: Synbiotics +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synbiotics + neomycin + mechanical bowel preparation (MBP)
Trial: 17443852
Drug: Mechanical bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mechanical bowel preparation only
Trial: 17443852
Drug: Neomycin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neomycin + mechanical bowel preparation (MBP)
Trial: 17443852
Drug: Synbiotics +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synbiotics + neomycin without mechanical bowel preparation (MBP)
Trial: 14995924
Drug: Prednisolone 5
RxNorm normalized name: prednisolone 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 5 mg daily for 10 days
Trial: 14995924
Drug: Promethazine 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Promethazine 75 mg daily for 10 days
Trial: 8373713
Drug: Zolpidem 5
RxNorm normalized name: zolpidem 5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem 5 mg
Trial: 28413900
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) + medication
Trial: 30110009
Drug: Aroma therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aroma therapy
Trial: 30110009
Drug: Joint-therapy (aroma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Joint-therapy (aroma therapy + music intervention)
Trial: 26036329
Drug: Oral terbinafine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral terbinafine
Trial: 25322165
Drug: Long-pulsed Nd:YAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-pulsed Nd:YAG laser treatment
Trial: 25322165
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (Oral terbinafine + Long-pulsed Nd:YAG laser)
Trial: 17624052
Drug: Heparin-coated catheter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-coated catheter with 50 mL/d of normal saline solution as a continuous infusion
Trial: 16291713
Drug: Buccal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Buccal administration of prochlorperazine
Trial: 16291713
Drug: Buccal administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Buccal administration of prochlorperazine, twice daily
Trial: 16291713
Drug: Oral tablet
RxNorm normalized name: Oral Tablet
DrugBank: Sodium citrate (DB09154)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral tablet of prochlorperazine
Trial: 7769597
Drug: Intrathecal morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal morphine 1.0 mg (n = 30)
Trial: 7769597
Drug: Intrathecal diamorphine
RxNorm normalized name: Diamorphine
DrugBank: Diamorphine (DB01452)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal diamorphine 0.75 mg (n = 30)
Trial: 17667723
Drug: Lactobacillus GG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus GG (LGG) 3 x 10 colony-forming units, twice daily for 4 weeks
Trial: 15363567
Drug: Transurethral ethanol
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transurethral ethanol ablation of the prostate (TEAP) using ProstaJect device, average ethanol injected 14 ml.
Trial: 7979340
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g of sucrose
Trial: 7979340
Drug: 4.34 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.34 g of saccharin
Trial: 2806714
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of atenolol (100 mg)
Trial: 2806714
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of atenolol (100 mg)
Trial: 27346074
Drug: Solifenacin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solifenacin (5 mg orally) on the day before, the day, and the day after TUR-BT
Trial: 27346074
Drug: Solifenacin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solifenacin (5 mg orally)
Trial: 26327130
Drug: AJM300 (960
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AJM300 (960 mg)
Trial: 20947097
Drug: Lung lavage
RxNorm normalized name: beef lung preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lung lavage with dilute bovine surfactant (two 15‐mL/kg aliquots)
Trial: 10971827
Drug: Interferon-alpha therapy
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha therapy for 16 or 32 weeks
Trial: 10971827
Drug: No further
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No further treatment after 16 weeks
Trial: 10971827
Drug: Prolonged treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged treatment for another 16 weeks
Trial: 8627059
Drug: High-dose didanosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose didanosine (ddI) 375 mg twice daily
Trial: 8627059
Drug: Low-dose didanosine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose didanosine (ddI) 100 mg twice daily
Trial: 9870319
Drug: Didanosine (ddI)
DrugBank: Didanosine (DB00900)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Didanosine (ddI) monotherapy
Trial: 29420536
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate hydration (250 ml 1.4%)
Trial: 29420536
Drug: Saline hydration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline hydration (1000 ml 0.9%)
Trial: 20722643
Drug: Double-dose misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Double-dose misoprostol 25 microg
Trial: 20722643
Drug: Dinoprostone 3
RxNorm normalized name: dinoprostone 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dinoprostone 3 mg
Trial: 28402415
Drug: Single-dose misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose misoprostol
Trial: 11912072
Drug: MMT (Methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMT (Methadone Maintenance Treatment)
Trial: 11912072
Drug: N-MMT (Non-Methadone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: N-MMT (Non-Methadone Maintenance Treatment)
Trial: 10522982
Drug: Androderm testosterone
RxNorm normalized name: testosterone Transdermal System [Androderm]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androderm testosterone transdermal system (TTD) - two 2.5-mg systems applied nightly
Trial: 10522982
Drug: Intramuscular testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular testosterone enanthate (i.m.) - 200 mg injected every 2 weeks
Trial: 8706192
Drug: Droperidol 1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 1.25 mg (n = 25)
Trial: 8706192
Drug: Droperidol 2.5
RxNorm normalized name: droperidol 2.5 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droperidol 2.5 mg (n = 25)
Trial: 7261688
Drug: Talampicillin (TMP)
RxNorm normalized name: talampicillin
DrugBank: Talampicillin (DB13814)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Talampicillin (TMP) 325 mg (equivalent to 200 mg ampicillin)
Trial: 7261688
Drug: Ampicillin (AMP)
RxNorm normalized name: Ampicillin
DrugBank: Ampicillin (DB00415)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ampicillin (AMP) 500 mg
Trial: 19890693
Drug: Local lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Local lidocaine injections during ESDs (mean dose 236 mg, mean volume 55.4 ml)
Trial: 19890693
Drug: Conventional normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional normal saline solution injections during ESDs (control group)
Trial: 19890693
Drug: Local lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Local lidocaine injections during ESDs (LG)
Trial: 9305556
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (10 g in 500 ml NSaline)
Trial: 8285082
Drug: Antacid containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid containing aluminum hydroxide
Trial: 3543246
Drug: 5-FU (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-FU (1,000 mg/m2 days 1 through 4) with bolus FA (200 mg/m2 days 1 through 4) - infusion arm
Trial: 3543246
Drug: 5-FU (325
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-FU (325 mg/m2 days 1 through 5) with bolus FA (200 mg/m2 days 1 through 5) - bolus arm
Trial: 26825109
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no intervention beyond regular osteoporosis treatment)
Trial: 31950924
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg mirabegron
Trial: 23079373
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg mirabegron
Trial: 17136293
Drug: Second-generation antihistamines
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-generation antihistamines
Trial: 17136293
Drug: Third-generation antihistamines
RxNorm normalized name: Ahist Antihistamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Third-generation antihistamines
Trial: 15078430
Drug: Clotrimazole 500
RxNorm normalized name: clotrimazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clotrimazole 500 mg single dose vaginal tablet (VT)
Trial: 15078430
Drug: Clotrimazole 10%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clotrimazole 10% single dose vaginal cream (VC)
Trial: 15078430
Drug: Fluconazole 150
RxNorm normalized name: fluconazole 150 MG
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole 150 mg single dose oral capsule (Diflucan)
Trial: 15078430
Drug: Clotrimazole 500
RxNorm normalized name: clotrimazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clotrimazole 500 mg VT and Clotrimazole 10% VC
Trial: 15078430
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (Clotrimazole and Fluconazole)
Trial: 8001522
Drug: Riboflavin intake
RxNorm normalized name: Riboflavin
DrugBank: Riboflavin (DB00140)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Riboflavin intake (average daily intake above 0.5 mg/1000 kcal)
Trial: 9084065
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg oral adinazolam mesylate SR tablets
Trial: 9084065
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg parenteral (i.v.) adinazolam mesylate
Trial: 9084065
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg i.v. NDMAD
Trial: 8441129
Drug: Cream based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream based preparation
Trial: 3538742
Drug: Pulsatile insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pulsatile insulin infusion (1 1/2 to 2 1/4 min pulses followed by 10 1/2 to 9 3/4 min intervals)
Trial: 3538742
Drug: Continuous insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous insulin infusion (0.45 mU/kg X min)
Trial: 27171969
Drug: Topical Furosemide
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical Furosemide
Trial: 24719126
Drug: Intracoronary abciximab
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary abciximab (0.25 mg/kg)
Trial: 21098442
Drug: Intravenous abciximab
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous abciximab (0.25 mg/kg)
Trial: 18950458
Drug: DaunoXome (DNX)
RxNorm normalized name: daunorubicin liposomal Injection [DaunoXome]
DrugBank: Daunorubicin (DB00694)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: DaunoXome (DNX) 80 mg/m(2) days 1‐3 plus cytarabine (AraC; 100 mg/m(2) days 1‐7)
Trial: 18950458
Drug: Daunorubicin (DNR)
RxNorm normalized name: daunorubicin
DrugBank: Daunorubicin (DB00694)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Daunorubicin (DNR) 45 mg/m(2) days 1‐3 plus cytarabine (AraC; 100 mg/m(2) days 1‐7)
Trial: 15899106
Drug: Ezetimibe 10mg
RxNorm normalized name: EZETIMIBE 10MG TAB
DrugBank: Ezetimibe (DB00973)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ezetimibe 10mg co-administered with simvastatin 10mg or 20mg
Trial: 15899106
Drug: Placebo co-administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo co-administered with simvastatin 10mg or 20mg
Trial: 11780237
Drug: Scaling and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scaling and root planing combined with local application of 2% minocycline hydrochloride ointment (Periocline)
Trial: 8829939
Drug: diclofenac 75
RxNorm normalized name: CAPSAICIN 0.025%/DICLOFENAC 75MG KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: diclofenac 75 mg intramuscularly (i.m.)